Fintel reports that on March 20, 2025, Wolfe Research initiated coverage of InvenTrust Properties (NYSE:IVT) with a Peer ...

As previously reported, Wolfe Research initiated coverage of Blueprint Medicines (BPMC) with an Outperform rating and $132 price target. The ...

Wolfe Research initiated coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report published on ...

Wolfe Research initiated coverage of Spyre Therapeutics (SYRE) with an Outperform rating and $27 price target The company is an early stage ...

Wolfe Research assumed coverage on shares of Spyre Therapeutics (NASDAQ:SYRE – Get Free Report) in a research report issued ...

Micron Technology (MU) is scheduled to report results of its fiscal second quarter after the market close on Thursday, March 20, with a ...

Verizon Communications Inc.’s stock has beaten the S&P 500 so far this year, but a Wolfe Research analyst is recommending ...

On Tuesday, March 18 at 12:30 PM ET, Rivian (NASDAQ: RIVN) Founder and CEO RJ Scaringe will participate in a fireside chat at the Wolfe Research Virtual Autos Summit. Emmanuel Rosner and Shreyas ...

Investing.com -- Wolfe Research analysts cut their price target on Micron Technology (NASDAQ:MU) shares to reflect the recent management’s commentary that pointed to short-term headwinds.

Wolfe analysts dubs WhatsApp business messaging a huge opportunity For Meta. They see upside in Meta stock to $730.

Tuesday, Wolfe Research initiated coverage on Blueprint Medicines (NASDAQ:BPMC) with an Outperform rating, signaling optimism for the company’s financial prospects. Currently valued at $5.89 billion, ...